PANEL 1
8:40 AM - 9:35 AM
Transforming Innovation into Patient Outcomes: Grounded in Community, Guided by Science
chair
Katie Mazuk
Chief Patient Experience Officer, Novartis US
PANELISTS
Uché Blackstock
Founder & CEO, Advancing Health Equity
Michael Hodin
CEO, Global Coalition on Aging
Molly Guthrie
VP, President, Policy & Advocacy, Susan G. Komen
John M. O’Brien
CEO, National Pharmaceutical Council (invited)
CHAIR
Vice President & Publisher, Scientific American
PANELISTS
Michael Clinton
Founder & CEO, ROAR Forward
Patrick Kullenberg
Chief Innovation Officer, L’Oréal North America
David Luu
Founder, Longevity Docs
Qian Zheng
SVP Advanced Research, Head of the Global Regenerative Beauty Discovery Domain, L’Oréal North America
CHAIR
Keri Hildick
Chief Strategy Officer, Perspectum
PANELISTS
Jaime Almandoz
Associate Professor of Internal Medicine & Medical Director, Weight Wellness Program, UT Southwestern Medical Center
Manu Chakravarthy
SVP & Global Head of Cardiovascular, Renal, and Metabolism Product Development, Roche
Sandra Elia
Chair, Obesity Matters
Priya Jaisinghani
Clinical Assistant Professor, ABC News Medical Unit Contributor, NYU/ABC News
CHAIR
Tania Simoncelli
Vice President, Translational Impact and Engagement, Chan Zuckerberg Initiative
PANELISTS
Marianne Clancy
CEO and Managing Director, Strategic Partnerships, Cure HHT
Michaela Dinboeck
Head, Patient Engagement, Novartis
Sunitha Malepati
VP & Treasurer, CACNA1A Foundation and Founder & CEO, Buffalo Initiative
Amit Rakhit
Chief Medical Officer, BlueRock Therapeutics
Josh Sommer
Co-Founder & Executive Director, Chordoma Foundation
CHAIR
Eric Horvitz
Chief Scientific Officer, Microsoft
PANELISTS
Grace Cordovano
CEO | Board-Certified Patient Advocate, Enlightening Results, LLC
David C. Fajgenbaum
Co-Founder & President, Every Cure
Aaron Mitchell
Life Sciences Global R&D Leader, ZS
Anne Wojcicki
President, TTAM Research Institute; Co-Founder, Former Chief Executive Officer, 23andMe (invited)
MODERATOR
Greta Van Susteren
Anchor & Host, «The Record with Greta Van Susteren,» Newsmax TV
PANELISTS
Mikael Dolsten
Former Chief Scientific Officer and President, Pfizer Research & Development
Ify Osunkwo
Chief Patient Officer & VP, Rare Disease, Novo Nordisk ; Director, Sickle Cell Transitions Program
Swee Lay Thein
Senior Investigator, Sickle Cell Genetics and Pathophysiology, NIH (invited)
CO-MODERATORS
Karla Childers
Vice President, Bioethics, Policy & Partnerships, Johnson & Johnson
Aaron Leibtag
CEO & Co-Founder, Pentavere
TOP SCIENTISTS & KOL
Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.
PREVIOUS DEBATES